# Peapack Gladstone Financial Corp: overview

PGC · Nasdaq · CIK 1050743 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/pgc.md) · [Financials](/companies/pgc/financials.md) · [Filings](/companies/pgc/filings.md) · [Insiders](/companies/pgc/insiders.md)

Latest reported revenue: [$86.1m](/filings/0001193125-26-339645.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 7, 2026 (XBRL us-gaap:Revenues, accession 0001193125-26-339645).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [56.6](/filings/0001193125-25-271685.md) | [61.8 d](/filings/0001193125-26-101763.md) | [64.4](/filings/0001193125-26-213949.md) | [69.7](/filings/0001193125-26-339645.md) | [70.7](/filings/0001193125-25-271685.md) | [78.2 d](/filings/0001193125-26-101763.md) | [82.5](/filings/0001193125-26-213949.md) | [86.1](/filings/0001193125-26-339645.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [13.4%](/filings/0001193125-26-101763.md) | [14.9% d](/filings/0001193125-26-101763.md) | [11.8%](/filings/0001193125-26-213949.md) | [11.4%](/filings/0001193125-26-339645.md) | [13.6%](/filings/0001193125-26-101763.md) | [15.5% d](/filings/0001193125-26-101763.md) | [17.2%](/filings/0001193125-26-213949.md) | [18.6%](/filings/0001193125-26-339645.md) |
| Diluted EPS | $ per share | [0.43](/filings/0001193125-26-101763.md) | [0.52](/filings/0001193125-26-101763.md) | [0.43](/filings/0001193125-26-213949.md) | [0.45](/filings/0001193125-26-339645.md) | [0.54](/filings/0001193125-26-101763.md) | [0.69](/filings/0001193125-26-101763.md) | [0.80](/filings/0001193125-26-213949.md) | [0.86](/filings/0001193125-26-339645.md) |
| Free cash flow | $m | [23.0 d](/filings/0001193125-25-271685.md) | [22.4 d](/filings/0001193125-26-101763.md) | [(11.5)](/filings/0001193125-26-213949.md) | [9.9 d](/filings/0001193125-26-339645.md) | [34.0 d](/filings/0001193125-25-271685.md) | [(3.6) d](/filings/0001193125-26-101763.md) | [23.3](/filings/0001193125-26-213949.md) | [48.6 d](/filings/0001193125-26-339645.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [210](/filings/0000950170-24-029761.md) | [242](/filings/0000950170-25-037821.md) | [230](/filings/0001193125-26-101763.md) | [228](/filings/0001193125-26-101763.md) | [283](/filings/0001193125-26-101763.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [26.9%](/filings/0000950170-24-029761.md) | [30.6%](/filings/0000950170-25-037821.md) | [21.3%](/filings/0001193125-26-101763.md) | [14.5%](/filings/0001193125-26-101763.md) | [13.2%](/filings/0001193125-26-101763.md) |
| Diluted EPS | $ per share | [2.93](/filings/0000950170-24-029761.md) | [4.00](/filings/0000950170-25-037821.md) | [2.71](/filings/0001193125-26-101763.md) | [1.85](/filings/0001193125-26-101763.md) | [2.10](/filings/0001193125-26-101763.md) |
| Free cash flow | $m | [71.5](/filings/0000950170-24-029761.md) | [115](/filings/0000950170-25-037821.md) | [66.8](/filings/0001193125-26-101763.md) | [63.0](/filings/0001193125-26-101763.md) | [28.8](/filings/0001193125-26-101763.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/pgc/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $75.6m | 1,597,272 |  | Added +125,923 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $49.0m | 1,035,542 |  | Added +451 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $33.4m | 705,681 |  | Added +19,617 |
| [WELLINGTON MANAGEMENT GROUP LLP](/funds/902219.md) | 2026-06-30 | $31.9m | 674,880 |  | Added +38,797 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $26.9m | 569,369 |  | Added +52,457 |
| [Boston Partners](/funds/1386060.md) | 2026-06-30 | $22.1m | 467,556 |  | Reduced −28,716 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $22.0m | 464,052 |  | Added +72,659 |
| [AMERICAN CENTURY COMPANIES INC](/funds/748054.md) | 2026-06-30 | $21.7m | 458,345 |  | Added +89,530 |
| [BROWN ADVISORY INC](/funds/1345929.md) | 2026-06-30 | $21.3m | 450,880 |  | Reduced −5,386 |
| [STRATEGIC VALUE BANK PARTNERS LLC](/funds/1904067.md) | 2026-06-30 | $17.9m | 378,416 |  | Unchanged |

## Recent filings

[All 1,324 filings](/companies/pgc/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-27 | 16:39 ET | [8-K](/filings/0001193125-26-434327.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-434327 |
| 2026-08-07 | 11:46 ET | [10-Q](/filings/0001193125-26-339645.md) | Quarterly report, period 2026-06-30 | 0001193125-26-339645 |
| 2026-07-27 | 16:52 ET | [8-K](/filings/0001193125-26-318213.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-318213 |
| 2026-05-08 | 12:14 ET | [10-Q](/filings/0001193125-26-213949.md) | Quarterly report, period 2026-03-31 | 0001193125-26-213949 |
| 2026-04-30 | 11:28 ET | [8-K](/filings/0001193125-26-195221.md) | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-195221 |
| 2026-04-24 | 15:22 ET | [8-K/A](/filings/0001193125-26-176900.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-176900 |
| 2026-04-22 | 16:43 ET | [8-K](/filings/0001193125-26-170627.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-170627 |
| 2026-03-26 | 09:29 ET | [8-K](/filings/0001193125-26-125298.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-125298 |
| 2026-03-16 | 15:35 ET | [DEF 14A](/filings/0001193125-26-108191.md) | Proxy statement, period 2026-04-29 | 0001193125-26-108191 |
| 2026-03-11 | 13:55 ET | [10-K](/filings/0001193125-26-101763.md) | Annual report, period 2025-12-31 | 0001193125-26-101763 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-101763.md), filed Mar 11, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, locked when the 8-K was accepted. It is scored when the 10-Q or 10-K is ingested. [See the target](/leagues/2026q3/targets/f6f47159-44b9-4500-a80e-8c6b49effb34)

## About the filer

- CIK: 1050743
- Tickers: PGC
- Exchange: Nasdaq
- SIC code: 6029 Commercial Banks, NEC
- State of incorporation: NJ
- Filer category: Accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 27, 2026, 16:40 ET. No prices; not investment advice.